You're viewing a teaser listing

Sign in free to unlock revenue, deal size, and the seller narrative. Unlock named contact with credits after you sign in.

Tablet & syrup pharma plant raising ₹8Cr for WHO-GMP capacity

Strategic Partner

Live

Revenue, EBITDA, growth, and ticket size unlock with a free account.

Your checklist as an investor

Intro -> diligence (off-platform) -> term sheet -> close

1
Get an initial report
Order a third-party investment report to gauge whether the deal is worth pursuing.
2
Review the deal
Study the metrics, documents and valuation.
3
Unlock & connect
Spend 1 credit to swap contact details with the seller.
4
Run diligence
Bring in a CA / CS / legal professional to verify.
5
Send a term sheet
Propose the amount, instrument and rights.
6
Close in escrow
Settle securely through partner-assisted escrow.

Overview

Business description, sale rationale, and verification detail unlock after sign-in.

Initial investment report

A short report on this business covering the previous years' financials, some investment highlights and the risks - enough to tell you, at a high level, whether this deal is worth taking further.

Read this first

It is for initial exploration only - an indication of whether a deal is worth going forward with, not diligence and not advice.
It carries none of CapitalSea's own opinions. We hold no view on this business and we do not shape what the report says.
It is researched and written by a third party, not by CapitalSea. We neither verify nor endorse what it says.